In a secret shopper study of 35 Bay Area dispensaries, budtenders consistently recommended topicals for pain (77%) and edibles for sleep (60%), with advice based more on personal experience than scientific evidence.
Cannabis consumers, researchers designing clinical trials, dispensary training programs, cannabis regulators
What the researchers found
Across 35 Bay Area dispensaries, budtenders showed strong consensus: 77% recommended topicals for pain and 60% recommended edibles for sleep. For pain, high CBD:THC ratios (28.6%) and 1:1 ratios (28.6%) were most endorsed. For sleep, THC alone was most recommended (34.3%) and 57% endorsed indica strains. When asked about their basis for recommendations, budtenders cited personal experience and perceived product effectiveness. Most (85.7%) expressed no strain preference for pain.
Why it matters
With limited physician guidance on cannabis, dispensary budtenders are the de facto advisors for millions of cannabis consumers. Their recommendations for topicals (pain) and edibles (sleep) are testable hypotheses that could drive clinical research priorities.
The numbers in context
35 of 42 dispensaries visited; pain: 77.1% recommended topicals, 28.6% high CBD:THC, 28.6% 1:1 ratio; sleep: 60% recommended edibles, 34.3% THC alone, 57.1% indica strains; recommendations based on personal experience
How the study worked
Secret shopper observational study visiting 35 of 42 cannabis dispensaries in Alameda and San Francisco Counties, California. Researchers asked budtenders for recommendations on products, dosage, and strains for pain and sleep relief.
What this study cannot tell us
Secret shopper approach in one geographic area. Bay Area dispensaries may not represent other markets. Cannot verify accuracy of budtender recommendations. No assessment of customer outcomes from following these recommendations. Budtender training varies widely.
How to read the evidence
Preliminary: observational secret shopper study capturing real-world advice patterns, but not assessing effectiveness of recommendations.
When this study was published
2025 publication
The bigger picture
There is a fundamental mismatch: most cannabis clinical trials study smoked or oral cannabis, while the products budtenders actually recommend (topicals, edibles, specific ratios) have far less clinical evidence behind them. Research should follow real-world recommendation patterns.
Questions still open
- Are topical preparations actually effective for pain as budtenders suggest?
- Should dispensary budtender training include evidence-based education?
Read the original research
Dispensing Medical Advice: San Francisco Bay Area Budtender Recommendations for Pain and Sleep Relief.
Cannabis (Albuquerque, N.M.), 8(3), 1-8
Citation
Hoang, Christine; Holmes, Louisa M; Ling, Pamela M. (2025). Dispensing Medical Advice: San Francisco Bay Area Budtender Recommendations for Pain and Sleep Relief.. Cannabis (Albuquerque, N.M.), 8(3), 1-8. https://doi.org/10.26828/cannabis/2025/000328
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk